New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S3616

Introduced
9/19/24  
Refer
9/19/24  

Caption

Requires health care professionals to perform lead screening on pregnant persons under certain circumstances.

Impact

Should this bill be enacted, it would supplement existing public health laws in New Jersey regarding maternal care and lead screening. This act would require a systematic approach to lead exposure assessments during prenatal care, thereby establishing a clearer pathway for early detection and intervention. Furthermore, the bill enforces confidentiality protocols regarding the reporting of lead screening results, ensuring that patient information is protected while contributing to a central database aimed at improving public health outcomes.

Summary

Senate Bill S3616 is a public health initiative aimed at addressing lead exposure among pregnant individuals. The bill mandates that licensed healthcare professionals assess pregnant patients for potential risk factors associated with lead exposure and conduct lead screenings if any risk factors are identified, in accordance with the latest guidelines from authoritative health organizations like the CDC. This requirement is intended to protect both the health of the pregnant person and the developing fetus from the harmful effects of lead poisoning, which is particularly concerning given the risks associated with elevated blood lead levels.

Sentiment

The sentiment around SB S3616 appears to be supportive, especially among health advocacy groups and professionals who advocate for preventative healthcare measures. The emphasis on preventive screenings is generally viewed positively as a necessary step in safeguarding maternal and child health. However, there may be concerns from some healthcare providers about the feasibility and implications of the implementation of such mandatory screenings within existing healthcare frameworks.

Contention

While the bill is largely seen as a progressive move towards enhancing public health safeguards, there may be points of contention regarding the logistics of implementation—specifically, how healthcare professionals will integrate these new screening requirements into their practices. Some may argue that additional costs or administrative burdens could arise from the need to perform these screenings and report results, which could affect the accessibility of care. Balancing the need for comprehensive health monitoring with the possible implications for healthcare providers will be an important consideration moving forward.

Companion Bills

NJ A4848

Same As Requires health care professionals to perform lead screening on pregnant persons under certain circumstances.

Previously Filed As

NJ A2225

Requires health care professionals to perform lead screening on pregnant persons under certain circumstances.

NJ S3897

Requires performance of myeloma screening under certain circumstances.

NJ S2214

Requires certain ultrasounds on pregnant women to be performed by licensed health care professionals.

NJ S2580

Requires certain providers to perform intimate partner violence screenings and all health care professionals to take certain actions to prevent perpetrator of intimate partner violence from obtaining copies of victim's medical record.

NJ A2007

Requires certain providers to perform intimate partner violence screenings and all health care professionals to take certain actions to prevent perpetrators of intimate partner violence from obtaining copies of victim's medical record.

NJ SB174

Provides relative to certain pregnancy screenings. (gov sig) (EN INCREASE GF EX See Note)

NJ A2668

Requires screening of certain high-risk pregnancies and reporting of fetal deaths.

NJ A3723

Requires licensed health care professionals providing prenatal care to offer and screen, upon request, pregnant patients with history of depression for postpartum depression.

NJ S2250

Requires licensed health care professionals providing prenatal care to offer and screen, upon request, pregnant patients with history of depression for postpartum depression.

NJ A4916

Requires health insurers to cover colorectal cancer screenings for covered persons aged 33 or over and covered persons under the age of 33 if deemed medically necessary.

Similar Bills

IA HSB85

A bill for an act relating to testimony at involuntary commitment hearings by physician assistants and advanced registered nurse practitioners.(See HF 313.)

IA HF313

A bill for an act relating to testimony at involuntary commitment hearings by physician assistants and advanced registered nurse practitioners.(Formerly HSB 85.)

NJ A2492

Expands number of health care professions profiled under "New Jersey Health Care Consumer Information Act."

CA AB2311

Health care districts: employment.

OH HB377

Regards use of light-based medical devices for hair removal

OH SB226

Regards use of light-based medical devices for hair removal

IA HSB502

A bill for an act relating to health insurers' credentialing process.

WV SB471

Authorizing physician assistants to own business